LDLR and metabolic dysfunction-associated steatotic liver disease: To better explore the protective effects of reshaping intestinal microbiome by antibiotics on hyperlipidemia-associated atherosclerosis and NAFLD in CHL patients, we subjected LDLR-/- hamsters to an HC diet (Fig. S5A).